Grok vs Qwen for Legal

Draft NDA Clause: Mutual Protection of Trade Secrets

Below is a sample clause for a mutual Non-Disclosure Agreement (NDA) that protects both parties' trade secrets. This clause is drafted to be balanced, enforceable under U.S. law (e.g., aligning with the Defend Trade Secrets Act (DTSA) and Uniform Trade Secrets Act (UTSA)), and includes a carve-out for required disclosures to regulatory authorities. It assumes a broader agreement context; customize it with defined terms, governing law, and specifics as needed.

---

3. Protection of Trade Secrets and Confidential Information.

(a) Definition. “Trade Secrets” means any confidential or proprietary information of a Disclosing Party (including, without limitation, technical data, know-how, formulas, processes, designs, algorithms, software code, business plans, customer lists, financial information, and marketing strategies) that (i) derives independent economic value, actual or potential, from not being generally known to, and not being readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use, and (ii) is the subject of reasonable efforts by the Disclosing Party to maintain its secrecy. “Confidential Information” means Trade Secrets and any other non-public information disclosed by a Disclosing Party to a Receiving Party, whether orally or in writing, that is designated as confidential or that reasonably should be understood to be confidential given the nature of the information and the circumstances of disclosure.

(b) Obligations. Each party (the “Receiving Party”) agrees: (i) to hold the Disclosing Party’s Trade Secrets and Confidential Information in strict confidence; (ii) not to disclose such information to any third party except as expressly permitted herein; and (iii) not to use such information except as necessary to perform its obligations or exercise its rights under this Agreement. The Receiving Party shall protect the Disclosing Party’s Trade Secrets and Confidential Information using at least the same degree of care that it uses to protect its own confidential information of a similar nature, but in no event less than a reasonable degree of care.

(c) Permitted Disclosures. Notwithstanding Section 3(b), the Receiving Party may disclose Trade Secrets or Confidential Information:
(i) to its directors, officers, employees, contractors, agents, or professional advisors (collectively, “Representatives”) who have a need to know such information for purposes of this Agreement and who are bound by written confidentiality obligations at least as protective as those herein;
(ii) as required by applicable law, regulation, or court or administrative order (including disclosures to regulatory authorities such as the Securities and Exchange Commission (SEC), Federal Trade Commission (FTC), or equivalent bodies), provided that the Receiving Party (A) gives the Disclosing Party prompt written notice of such requirement (unless prohibited by law) to allow the Disclosing Party to seek a protective order or other remedy, (B) discloses only the minimum portion of Trade Secrets or Confidential Information required to comply, and (C) reasonably cooperates with the Disclosing Party’s efforts to obtain confidential treatment; or
(iii) with the Disclosing Party’s prior written consent.

(d) Exclusions. The obligations in this Section 3 do not apply to information that: (i) is or becomes publicly available through no fault of the Receiving Party; (ii) was rightfully known to the Receiving Party prior to disclosure by the Disclosing Party; (iii) is rightfully received from a third party without breach of any confidentiality obligation; or (iv) is independently developed by the Receiving Party without use of or reference to the Disclosing Party’s Trade Secrets or Confidential Information.

(e) Duration. The obligations with respect to Trade Secrets shall continue for so long as such information qualifies as a trade secret under applicable law. Obligations with respect to other Confidential Information shall continue for [●] years from the date of disclosure (or such longer period as the parties may agree).

(f) Return or Destruction. Upon the Disclosing Party’s request or termination of this Agreement, the Receiving Party shall promptly return or destroy (and certify destruction of) all copies of the Disclosing Party’s Trade Secrets and Confidential Information, except as required by law or for archival purposes under a documented retention policy.

(g) Remedies. The parties acknowledge that any breach of this Section 3 may cause irreparable harm for which monetary damages are inadequate. The Disclosing Party shall be entitled to seek injunctive relief without posting a bond, in addition to any other remedies available at law or in equity.

---

Key Legal Considerations

When drafting and implementing this clause, consider the following to ensure enforceability, balance, and compliance:

1. Alignment with Trade Secret Law (DTSA and UTSA):

   • Definitions must mirror statutory standards (e.g., economic value from secrecy and reasonable secrecy efforts) to support claims under federal (DTSA, 18 U.S.C. § 1836) or state law. Courts require evidence of "reasonable measures" to protect secrets (e.g., NDAs, access controls).
   • Perpetual protection for true trade secrets is standard and enforceable; time limits apply only to non-trade secret confidential info to avoid overreach.

2. Mutuality and Consideration:

   • Ensure the NDA is mutual to protect both parties equally. Provide consideration (e.g., mutual exchange of info or business opportunity) to make it binding.

3. Regulatory Disclosure Carve-Out:

   • The "required by law" exception is critical for compliance (e.g., SEC filings under Regulation FD or FDA reporting). The notice-and-cooperate mechanism preserves secrecy where possible and aligns with DTSA safe harbors for whistleblowers (18 U.S.C. § 1833(b)), protecting against claims of waiver.
   • Specify minimum disclosure to limit exposure; regulators often allow redactions.

4. Enforceability and Jurisdiction:

   • Specify governing law (e.g., Delaware for business NDAs) and venue. Include severability for invalid provisions.
   • Avoid overly broad language (e.g., no "all information" without designation) to prevent courts from striking the clause as unreasonable.

5. Exceptions and Defenses:

   • Standard exclusions prevent disputes over public or independently developed info. Require documentation (e.g., timestamps) to prove independent development.

6. Remedies and Injunctive Relief:

   • "Irreparable harm" language facilitates preliminary injunctions under DTSA. Explicitly waive bond requirements where jurisdiction allows.

7. Practical Implementation:

   • Marking/Designation: Orally disclosed info should be confirmed in writing within a set period (e.g., 30 days).
   • Duration: Tailor to industry (e.g., 5-10 years for tech).
   • International Considerations: Address export controls (e.g., EAR/ITAR), GDPR/CCPA for data privacy, and conflicts with foreign laws.
   • Audit Rights: Optionally add rights to audit compliance.

8. Risks and Best Practices:

   • Over-Disclosure: Train employees; use data rooms for sharing.
   • Breach Response: Include notice periods for cure.
   • Whistleblower Protections: DTSA immunizes disclosures to government or attorneys for reporting violations.
   • Consult counsel for customization, as enforceability varies by jurisdiction (e.g., California bans non-compete ties).

This draft is a starting point; have it reviewed by legal counsel for your specific context.

Disclaimer: I am an artificial intelligence, not an attorney. The following draft and analysis are for informational and educational purposes only and do not constitute legal advice. Laws regarding trade secrets and regulatory disclosures vary significantly by jurisdiction (e.g., state, federal, international). You should consult with qualified legal counsel to tailor this clause to your specific situation and ensure compliance with applicable laws.

---

Draft Clause: Mutual Confidentiality and Regulatory Exception

Section X. Confidentiality Obligations and Regulatory Disclosures

X.1 Mutual Obligation. Each Party (the "Receiving Party") agrees to hold in strict confidence all Confidential Information disclosed by the other Party (the "Disclosing Party"). The Receiving Party shall not disclose, reproduce, or use any Confidential Information except for the Purpose defined in this Agreement. This obligation applies mutually to both Parties.

X.2 Trade Secrets. The Parties acknowledge that certain Confidential Information may constitute trade secrets under applicable law (including the Defend Trade Secrets Act of 2016, if applicable). Notwithstanding any other provision in this Agreement to the contrary, any information identified or that reasonably should be understood to constitute a trade secret shall remain protected indefinitely and shall not be subject to the expiration terms applicable to general Confidential Information.

X.3 Regulatory and Legal Compulsion. Notwithstanding the foregoing, a Receiving Party may disclose Confidential Information if such disclosure is legally required by a valid order of a court, government agency, or regulatory authority (a "Regulatory Request"). However, such disclosure is permitted only under the following conditions:

• (a) Prior Notice: The Receiving Party shall provide the Disclosing Party with prompt written notice of the Regulatory Request prior to disclosure, unless strictly prohibited by law or the Regulatory Request itself.
• (b) Scope Limitation: The Receiving Party shall disclose only that portion of the Confidential Information that is strictly required to comply with the Regulatory Request.
• (c) Cooperation: The Receiving Party shall reasonably cooperate with the Disclosing Party, at the Disclosing Party's expense, to seek a protective order, confidential treatment, or other assurance that the Confidential Information will be accorded confidential status by the regulatory authority or court.

X.4 Whistleblower Immunity. Nothing in this Agreement is intended to impede, restrict, or prevent either Party or their respective employees from reporting possible violations of federal law or regulation to any governmental agency or entity, including but not limited to the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, or making other disclosures under the whistleblower provisions of federal law or regulation. No Party requires prior authorization for such disclosures, nor shall they provide notice to the other Party regarding such disclosures.

---

Key Legal Considerations

When drafting and negotiating this clause, several critical legal dynamics must be balanced to ensure enforceability and adequate protection.

1. The "Indefinite" Nature of Trade Secrets

• Consideration: General confidential information (e.g., business plans, contact lists) usually has a set expiration date (e.g., 2 or 5 years). Trade secrets (e.g., the Coca-Cola formula, proprietary algorithms), by definition, lose protection if they become public.
• Drafting Strategy: Section X.2 explicitly carves out trade secrets from the standard expiration timeline. If the NDA expires but the information is still a trade secret, the obligation must survive indefinitely. Failure to include this can inadvertently publish a trade secret once the contract term ends.

2. Balancing Compelled Disclosure vs. Protection

• Consideration: A party cannot contractually agree to ignore a subpoena or a lawful regulatory demand. However, a blanket exception allows a party to be too cooperative with regulators, potentially harming the other side.
• Drafting Strategy: Section X.3 creates a "safe harbor." It acknowledges the legal duty to disclose but imposes procedural hurdles:
  • Notice: This allows the Disclosing Party to intervene (e.g., file a motion to quash) before the data is handed over.
  • "Unless Prohibited": This caveat is vital. In criminal investigations or SEC inquiries, tipping off the target is often illegal. The clause must承认 (acknowledge) that notice cannot be given if the law forbids it.
  • Minimization: Ensures the Receiving Party doesn't use the subpoena as an excuse to dump all the Disclosing Party's data into the public record.

3. The Defend Trade Secrets Act (DTSA) Notice

• Consideration: In the United States, the DTSA provides immunity to employees who disclose trade secrets in confidence to a government official or an attorney for the purpose of reporting a legal violation.
• Drafting Strategy: Section X.4 is often a statutory requirement. If an NDA does not include notice of this immunity, the company may be precluded from recovering exemplary damages or attorney's fees in a future trade secret misappropriation lawsuit. Even for mutual NDAs between companies, it is best practice to acknowledge that individual employees retain these statutory rights.

4. Jurisdictional Variance

• Consideration: "Regulatory Authorities" differ by industry and location. A clause designed for a US tech company may not suffice for an EU pharmaceutical company subject to GDPR or EMA regulations.
• Drafting Strategy: The term "Regulatory Request" should be interpreted in the context of the governing law clause of the main agreement. In the EU, data privacy laws may compel disclosure differently than US securities laws. Legal counsel must ensure the "Required by Law" definition aligns with local statutes.

5. Protective Orders and "Clawbacks"

• Consideration: Once information is submitted to a regulator, it may become subject to Freedom of Information Act (FOIA) requests or similar public access laws.
• Drafting Strategy: Section X.3(c) requires cooperation to seek "confidential treatment." In practice, this means marking submissions as "Confidential – Trade Secret" and working with the regulator to ensure the data is sealed or redacted before public release. This creates a contractual duty to actively fight for the other party's secrecy, not just passively allow the disclosure.

6. Mutual vs. Unilateral Protection

• Consideration: The prompt requests protection for both parties. Unilateral NDAs often favor the Disclosing Party.
• Drafting Strategy: The language uses "Each Party" and "Receiving/Disclosing Party" definitions that flip depending on who speaks. This ensures that if Party A is being investigated and must disclose Party B's secrets, Party A is bound by the notice/cooperation rules, and vice versa.

Recommendation

Before executing this agreement:

1. Define "Trade Secret": Ensure the main body of the NDA has a robust definition of what qualifies as a trade secret versus general confidential information.
2. Governing Law: Verify that the "Whistleblower Immunity" section complies with the specific state and federal laws governing the contract.
3. Specific Regulators: If you are in a highly regulated industry (Finance, Health, Defense), you may need to name specific agencies (e.g., FDA, FINRA, ITAR) to avoid ambiguity regarding what constitutes a valid regulatory disclosure.